ArticleJournal of cancer research and clinical oncology2022

In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide.

Tingyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.